Therapeutic Specialties Archives

Publication

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…

Jieun Choe2020年7月26日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020年7月14日

Publication

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…

Jieun Choe2020年7月14日

Blog

Local Therapies for the Global COVID-19 Pandemic

Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…

Certara2020年5月29日

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

Certara2020年4月30日

オンデマンド・ウェビナー

希少疾患治療薬のジレンマ：価値は高いが、価格も高く、アクセスは限定的？

This webinar will explain how pricing has evolved for the rare disease drug market and…

webdev2020年2月19日

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

webdev2020年1月17日

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

webdev2020年1月17日

Brochure

Simcyp：20年に渡るイノベーションの軌跡

The consortium members have partnered with Simcyp and Certara during the past 20 years to…

webdev2019年10月4日

On-Demand Webinar

希少疾患の治療薬を迅速に開発するための革新的なソリューション

This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…

webdev2019年8月10日

Powered by Translations.com GlobalLink Web Software

治療領域

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Local Therapies for the Global COVID-19 Pandemic

Applying decision analysis to drug development for COVID-19 & future pandemics

希少疾患治療薬のジレンマ：価値は高いが、価格も高く、アクセスは限定的？

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Simcyp：20年に渡るイノベーションの軌跡

希少疾患の治療薬を迅速に開発するための革新的なソリューション

メルマガ登録

クイックアクセス

ソリューション

お問合せ